Voran Group Ventures Ltd. (“Voran”) is pleased to report that it has closed a $1 million financing round with Sandstone Asset Management Inc. (“Sandstone”).
Sandstone is a wealth management firm based in Calgary, AB, offering discretionary investment management services to private individuals, foundations, and family trusts. The firm provides intelligent and independent investment expertise across a global portfolio of public and private investments. Sandstone’s Philosophy starts with people and ends with profit – fulfilling this calculated philosophy through dedication and continued examination of global investment opportunities.
Sharon Watkins, CEO of Sandstone said,
“Our investment in Voran Group is an endorsement of its people and ideas. It is a fusion of an attractive investment opportunity and supporting the potential of Canadian ingenuity that is essential to the future of our country. Sandstone is proud to support Voran Group’s future growth and its leadership in showing how Canadians can compete on the global biotech stage.”
Chelsey Reschke, President and CEO, commented:
“The alignments between Voran and Sandstone are centered on our mutual desire to “build”. And for Voran, we see this partnership as a critical step forward in our mission of improving the medical chemical market, specifically advanced antimicrobials, through products such as our flagship offering, Bacoban. We view Sandstone as an ideal partner capable of supporting our growth needs, which require us to further expand our team, secure the necessary raw materials to serve our customers, and diligently expand our claims through investing in scientific validation. We are pleased to have recently secured access to a highly capable GLP laboratory and are looking forward to refining our label across our key markets in Canada.”